搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
16 小时
on MSN
Adobe’s head of product is joining A24 to make movies
Belsky was also a driving force behind Adobe’s failed attempt to acquire rival product design platform Figma for $20 billion ...
FoodBusinessNews
15 小时
Kemin expands oxidation solutions portfolio
DES MOINES, IOWA — Kemin Industries has introduced a line of plant extract blends called Olessence. The ingredient range is ...
来自MSN
12 小时
4 Skills You Can Develop Quickly To Turn Into a Profitable Side Hustle
These four quick-to-learn skills could be your ticket to a profitable side hustle — and extra cash in your wallet.
FoodBusinessNews
15 小时
Technology extends shelf life of bread
Extending the shelf life of bread enables bakeries to centralize inventory in warehouses, allowing for broader customer reach ...
10 小时
Eli Lilly CEO Hasn’t Bought Company Shares in Years. He Just Bought This Stock.
Eli Lilly CEO David Ricks, also an Adobe director, paid $1 million on Jan. 28 for 2,250 shares of the software company.
14 小时
on MSN
Court sides against Deere in patent dispute over high-tech planters
John Deere loses patent dispute as a federal court rules in favor of AGCO, allowing rival high-speed planting tech to remain ...
Financial Planning
7 小时
Dynasty, LPL, Sequoia score big deals: Advisor Moves
JPMorgan also builds out the ranks of its private advisory group with execs poached from Goldman Sachs, Wells Fargo and Ernst ...
17 小时
AppFolio (APPF) Receives a Buy from D.A. Davidson
In a report released today, Gil Luria from D.A. Davidson reiterated a Buy rating on AppFolio (APPF – Research Report). The company’s shares ...
17 小时
Dynatrace (DT) Receives a Buy from D.A. Davidson
In a report released today, Gil Luria from D.A. Davidson reiterated a Buy rating on Dynatrace (DT – Research Report), with a price target of ...
The American Journal of Managed Care
11 小时
FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra
Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.
The American Journal of Managed Care
8 小时
FDA Approves First HER2-Ultralow Companion Diagnostic, Expanding Treatment Eligibility
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
Baking Business
15 小时
CME Group to introduce micro grain contracts
CHICAGO — CME Group, the world’s leading derivatives marketplace, on Jan. 31 announced it will launch a suite of micro grain ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈